FibroGen, Inc. (FGEN) NASDAQ
9.07
-0.15(-1.63%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
9.07
-0.15(-1.63%)
Currency In USD
| Market Cap | 35.5M |
| Enterprise Value | -12.37M |
| P/E Ratio | 0.25 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 3.78 |
| Price/Book Ratio | -3.02 |
| Enterprise/Revenue | -1.2 |
| Enterprise/EBITDA | 0.2 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 14.98 |
| Operating Margin | -5.96 |
| Return On Assets | 1.02 |
| Return On Equity | -1.82 |
| Revenue | 6.44M |
| Revenue/Share | 1.84 |
| Gross Profit | 0 |
| EBITDA | -45.9M |
| Net Income | 183.45M |
| Diluted EPS | 45.37 |
| Total Cash | 87.24M |
| Total Cash/Share | 21.56 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.61 |
| Book Value Per Share | -2.3 |
| 52-Week Change | -23.72 |
| 52-Week High | 21.95 |
| 52-Week Low | 4.85 |
| Moving Average 50 Days | 9.14 |
| Moving Average 200 Days | 8.84 |
| Average Volume | 33,227 |
| Shares Outstanding | 4.05M |
| % Held by Institutions | 28.46 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:25 |
| Last Split Date | June 17, 2025 |